Genome Editing Market Size to Reach USD 15.09 Billion in 2028 – Reports and Data

Rising prevalence of genetic disorders and chronic disorders, increasing advancements in gene therapy, and growing investment to accelerate genomics R&D are some key factors driving market growth

The global genome editing market size is expected to reach USD 15.09 Billion in 2028 at a CAGR of 14.8%, according to the latest report by Reports and Data. Growing application of genome editing in therapeutics and agricultural sector, development of CRISPR-based diagnostic tools, and rapid technological upgrades in genome editing tools are key factors expected to drive market revenue growth over the forecast period. In addition, growing use of gene editing tools such as CRISPR to disrupt genome and destroy SARS-CoV-2 cells inside human cells has also significantly contributed to revenue growth of the market.

Genome editing has expanded the scope of directly targeting and modifying genomic sequences in nearly all eukaryotic cells. Genome editing is a group of technologies that enables modifying and changing an organisms’ DNA. These technologies enable addition, removal, or alteration of genetic material at particular locations in the genome. Recent advances in gene editing approaches such as the advent of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-Cas9 has revolutionized gene editing. CRISPR is simpler, faster, cheaper, and highly accurate than conventional genome editing methods. Genome editing has been extensively used to understand the pathophysiology of different human diseases and has led to development of advanced gene therapies to treat severe diseases such as cystic fibrosis and diabetes.

Rising advancement in drug discovery and development and increasing government initiatives to accelerate research in genomics are some other key factors expected to drive market growth going ahead. However, ethical issues surrounding genome editing such as safety and high costs associated with gene therapies are expected to restrain market growth to a certain extent over the forecast period.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1052

Some Key Highlights from the Report:

  • CRISPR segment is expected to dominate other technology segments over the forecast period owing to a broad range of clinical applications of CRISPR such as in the treatment of diseases such as complex genetic diseases, AIDS, and cancer.
  • Advancements in gene editing systems and genetic engineering, increasing use of CRISPR gene editing in stem cell therapies, growing prevalence of autoimmune diseases and cancer, and increasing focus on stem cell research are some key factors contributing to revenue growth of the cell line engineering segment.
  • Pharma & biotech companies segment is expected to register significant revenue growth over the forecast period owing to increasing focus and advancements in genome editing techniques and genomic research to develop novel therapeutics due to growing prevalence of chronic and infectious diseases.
  • Asia Pacific is expected to register a robust revenue CAGR of 15.8% during the forecast period owing to increasing research and development activities in genomics, advancements in genetic engineering, and extensive academic and clinical research on CRISPR technology. In addition, presence of key pharmaceutical and biotechnology companies and growing financial support and funding from government are expected to further fuel revenue growth of the APAC market.
  • Key companies in the market include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs, Eurofins Scientific, and Sangamo Therapeutics, Inc.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/2769

For the purpose of this report, Reports and Data has segmented the global genome editing market on the basis of type, application, end-use and region:

Type Outlook (Revenue, USD Billion, 2018 - 2028)

  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Transcription Activator-Like Effector Nucleases (TALEN)
  • Zinc Finger Nucleases (ZFN)
  • Others

Application Outlook (Revenue, USD Billion, 2018 - 2028)

  • Animal Genetic Engineering
  • Therapeutic Application
  • Genetically Modified Organisms
  • Plant Genetic Engineering
  • Cell Line Engineering

End User Outlook (Revenue, USD Billion, 2018 - 2028)

  • Pharma & Biotech Companies
  • Academic Institutes & Research Center
  • Agrigenomic Companies
  • Contract Research Organizations (CROs)

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1052

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Pharma and Healthcare Industry:

Ankylosing Spondylitis (AS) Market Size, Share And Industry Analysis By Treatment Type (Medication, Surgery, Therapy, Others), By Care Providing Organization (Hospital, Care Home, Clinic, Others), By Application (Adults, Juveniles) And Region, Segment Forecasts To 2027

Diabetes Market By Disease Type, By Treatment Type, By Devices, By End-user And Segment Forecasts, 2019-2027

Organ Preservation Market Analysis, By Preservation Solutions (U.W. (University of Wisconsin), Custodial HTK, Perfadex), By Organ Types (Kidney, Liver, Lungs), By Techniques (Static Cold Storage, Dynamic Cold Storage) By End use (Organ Banks), Forecasts To 2026

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-genome-editing-market

Back to news